Pretreatment Predictors of Time to Cancer Specific Death After Prostate Specific Antigen Failure

Abstract

Patients at high risk for PSA failure after radiation therapy based on pretreatment PSA greater than 20 ng./ml. or biopsy Gleason score 4 + 3 or greater are also at high risk for death from prostate cancer after PSA failure despite competing causes of mortality.